Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma

Oncology Reports

Volumn 16, Issue 2, 2006, Pages 329-334

  Cai, Tommaso ^a   Nesi, Gabriella ^a   Boddi, Vieri ^a   Mazzoli, Sandra ^b   Dal Canto, Maurizio ^a   Bartoletti, Riccardo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

Author keywords

Bladder cancer; Inflammatory cells; Prognostic factors; Recurrence; Transitional cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER STAGING; DISEASE COURSE; FEMALE; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 33748544963     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.2.329     Document Type: Article

References (31)

1. Kurth KH, Bouffioux C, Sylvester R, van der Meijden AP, Oosterlinck W and Brausi M: Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group. Eur Urol 37: 1-9, 2000. (Pubitemid 30248573)
2. Kurth KH, Denis L, Bouffioux C, Sylvester R, Debruyne FM, Pavone-Macaluso M and Oosterlinck W: Factors affecting recurrence and progression in superficial bladder tumors. Eur J Cancer 31A: 1840-1846, 1995.
3. Malmstrom PU, Busch C and Norlen BJ: Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up. Scand J Urol Nephrol 21: 185-195, 1987.
4. Herr HW, Badalament RA, Amato DA, Laudone VP, Fair WR and Whitmore WF Jr: Superficial bladder cancer treated with bacillus Calmette-Guérin: a multivariate analysis of factors affecting tumor progression. J Urol 141: 22-29, 1989. (Pubitemid 19028816)
5. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Algaba F and Vicente-Rodriguez J: Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol 164: 680-684, 2000. (Pubitemid 30637601)
6. Holmang S, Hedelin H, Anderstrom C and Johansson SL: The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 153: 1823-1827, 1995.
7. Al-Sukhun S and Hussain M: Molecular biology of transitional cell carcinoma. Crit Rev Oncol Hematol 47: 181-193, 2003. (Pubitemid 36957861)
8. Theodorescu D: Molecular pathogenesis of urothelial bladder cancer. Histol Histopathol 18: 259-274, 2003.
9. Dalesio O, Schulman CC, Sylvester R, De Pauw M, Robinson M, Denis L, Smith P and Viggiano G: Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. J Urol 129: 730-733, 1983. (Pubitemid 13080873)
10. Cai T, Margallo E, Nesi G, Giubilei G, Rizzo M and Bartoletti R: Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up. Oncol Rep 15: 213-219, 2006.
11. Streeter EH and Harris AL: Angiogenesis in bladder cancer-prognostic marker and target for future therapy. Surg Oncol 11: 85-100, 2002. (Pubitemid 34606008)
12. Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG and Nichols PW: Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 87: 1603-1612, 1995.
13. Offersen BV, Knap MM, Marcussen N, Horsman MR, Hamilton-Dutoit S and Overgaard J: Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis. Br J Cancer 87: 1422-1430, 2002. (Pubitemid 36044318)
14. Flamm J and Benesch A: Tumor-associated mononuclear cell infiltrate and recurrence rate in the superficial urothelial carcinoma of the urinary bladder. Urol Int 41: 187-191, 1986. (Pubitemid 16040877)
15. Fujimoto Y, Hasegawa Y, Kato N, Sakai S, Kuriyama M, Kawada Y, Nishiura T, Takeuchi T and Isogai K: The study of infiltrating lymphocytes in the tissues of bladder carcinoma. Hinyokika Kiyo 29: 1037-1045, 1983.
16. Flamm J: The value of tumor-associated tissue inflammatory reaction in primary superficial bladder cancer. Urol Res 18: 113-117, 1990.
17. Kavanaugh DY and Carbone DP: Immunologic dysfunction in cancer. Hematol Oncol Clin North Am 10: 927-951, 1996. (Pubitemid 26240366)
18. McCarty WG: Principles of prognosis in cancer. JAMA 96: 30-33, 1936.
19. Takeuchi H, Maehara Y, Tokunaga E, Koga T, Kakeji Y and Sugimachi K: Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. Am J Gastroenterol 96: 574-578, 2001.
20. UICC International Union Against Cancer. TNM classification of malignant tumors. 6th edition. Wiley-Liss, New York, pp199-202, 2002.
21. Mostofi FK, Sobin LH and Torloni H: Histological typing of urinary bladder tumors. Geneva, World Health Organization, 1973.
22. Oosterlinck W, Lobel B, Jakse G, Malmström P, Stöckle M and Sternberg C (The EAU Working Group on Oncological Urology): Guidelines on Bladder Cancer. Eur Urol 41: 105-112, 2002.
23. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD and Hawkins IR: Superficial bladder cancer: progression and recurrence. J Urol 130: 1083-1086, 1983. (Pubitemid 14207227)
24. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E and Kosma V: Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182: 318-324, 1997. (Pubitemid 27285785)
25. Chouaib S, Asselin-Paturel A, Mami-Chouaib F, Caignard A and Blay JY: The host-tumor immune conflict. From immunosuppression to resistance and destruction. Immunol Today 18: 493-497, 1997. (Pubitemid 27441593)
26. Flamm J: Tumor-associated tissue inflammatory reaction and eosinophilia in primary superficial bladder cancer. Urology 40: 180-185, 1992.
27. Sarma KP: The role of lymphoid reaction in bladder cancer. J Urol 104: 843-849, 1970.
28. Stöber U: Der Einfluss der Lymphozyteinfiltration im Tumorgewebe auf Zeitpunkt und Infiltrationstendenz von Blasenkarzinomrezidiven. Urologe (A) 17: 296, 1978.
29. Bohle A: BCG's mechanism of action - increasing our understanding. For the EBIN Group. Eur Urol (suppl 1): 1-8, 2000.
30. Bartoletti R, Cai T, Nesi G, Sardi I and Rizzo M: Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: Relationship with clinical course at 10 years follow-up. Oncol Rep 14: 251-255, 2005.
31. Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Che X, Iwashige H, Aridome K, Hokita S and Aikou T: Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer 88: 577-583, 2000. (Pubitemid 30056932)